Department of Cardiovascular Surgery, the Second Xiangya Hospital of Central South University, Changsha, China.
Clinical Center for Gene Diagnosis and Therapy, Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
BMC Med Genomics. 2024 May 21;17(1):136. doi: 10.1186/s12920-024-01907-6.
Bosma arhinia microphthalmia syndrome (BAMS; MIM603457) is a rare genetic disorder, predominantly autosomal dominant. It is a multi-system developmental disorder characterized by severe hypoplasia of the nose and eyes, and reproductive system defects. BAMS is extremely rare in the world and no cases have been reported in Chinese population so far. Pathogenic variants in the SMCHD1 gene (MIM614982) cause BAMS, while the underlying molecular mechanisms requires further investigation.
In this study, a Chinese girl who has suffered from congenital absence of nose and microphthalmia was enrolled and subsequently submitted to a comprehensive clinical and genetic evaluation. Whole-exome sequencing (WES) was employed to identify the genetic entity of thisgirl. A heterozygous pathogenic variant, NM_015295, c.1025G > C; p. (Trp342Ser) of SMCHD1 was identified. By performing very detailed physical and genetic examinations, the patient was diagnosed as BAMS.
This report is the first description of a variant in SMCHD1 in a Chinese patient affected with BAMS.Our study not only furnished valuable genetic data for counseling of BAMS, but also confirmed the diagnosis of BAMS, which may help the management and prognosis for this patient.
Bosma 无鼻小眼综合征(BAMS;MIM603457)是一种罕见的遗传疾病,主要为常染色体显性遗传。它是一种多系统发育障碍,表现为严重的鼻和眼部发育不良,以及生殖系统缺陷。BAMS 在世界范围内极为罕见,迄今为止尚未在中国人群中报道过病例。SMCHD1 基因(MIM614982)中的致病性变异导致 BAMS,而潜在的分子机制需要进一步研究。
本研究纳入了一名患有先天性无鼻和小眼的中国女孩,并对其进行了全面的临床和遗传评估。采用全外显子组测序(WES)鉴定该女孩的遗传实体。发现 SMCHD1 基因的杂合致病性变异,NM_015295,c.1025G>C;p.(Trp342Ser)。通过进行非常详细的体格检查和基因检查,该患者被诊断为 BAMS。
本报告首次描述了中国 BAMS 患者 SMCHD1 中的变异。我们的研究不仅为 BAMS 的咨询提供了有价值的遗传数据,还确认了 BAMS 的诊断,这可能有助于该患者的管理和预后。